TABLE 1.

Anthracyclines, therapeutic use and maximum recommended cumulative dose.

Anthracycline	Clinical activity	Maximum cumulative dose
Daunorubicin	Treatment of acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, and Kaposi’s sarcoma	550 mg/m2
Doxorubicin	Treatment of breast cancer, bladder cancer, stomach cancer, lung cancer, acute lymphocytic leukemia, and Kaposi’s sarcoma	550 mg/m2
Epirubicin	Treatment of breast cancer, stomach cancer, lung cancer, urinary tract carcinoma, and ovarian carcinoma	900 mg/m2
Idarubicin	Treatment of acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myelogenous leukemia	150 mg/m2
Valrubicin	Treatment of bladder cancer	800 mg/m2